Application Nr Approved Date Route Status External Links
ANDA076607 2004-12-15 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Hypertension Quinapril Tablets Are Indicated For The Treatment Of Hypertension. It May Be Used Alone Or In Combination With Thiazide Diuretics. In Using Quinapril, Consideration Should Be Given To The Fact That Another Angiotensin-Converting Enzyme Inhibitor, Captopril, Has Caused Agranulocytosis, Particularly In Patients With Renal Impairment Or Collagen Vascular Disease. Available Data Are Insufficient To Show That Quinapril Does Not Have A Similar Risk (see Warnings) Angioedema In Black Patients Black Patients Receiving Ace Inhibitor Monotherapy Have Been Reported To Have A Higher Incidence Of Angioedema Compared To Non-Blacks. It Should Also Be Noted That In Controlled Clinical Trials Ace Inhibitors Have An Effect On Blood Pressure That Is Less In Black Patients Than In Non-Blacks.

All Formulated Excipients (7 Total)

Name Structure Kind Function Status
1. Lecithin LECITHIN Unresolved
2. Magnesium Carbonate MAGNESIUM CARBONATE Molecular B&N-Buffer & neutralizing agent FS-Substances permitted as optional ingredient in a standardized food.
3. Magnesium Stearate MAGNESIUM STEARATE Molecular AF-Antifoaming (or defoaming) agent , MISC-Miscellaneous REG-Food additives for which a petition has been filed and a regulation issued.
4. Cellulose, Microcrystalline CELLULOSE, MICROCRYSTALLINE Unresolved
5. Polyvinyl Alcohol POLYVINYL ALCOHOL Unresolved
6. Povidones POVIDONES Unresolved
7. Talc TALC Unresolved DYE-Dye GRAS-Generally recognized as safe.

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Quinapril Hydrochloride QUINAPRIL HYDROCHLORIDE ZINC3801163